Tashiro Takuya, Nakagawa Ryusuke, Hirokawa Takatsugu, Inoue Sayo, Watarai Hiroshi, Taniguchi Masaru, Mori Kenji
Glycosphingolipid Synthesis Group, Laboratory for Immune Regulation, Research Center for Allergy and Immunology, RIKEN, Hirosawa 2-1, Wako-shi, Saitama 351-0198, Japan.
Bioorg Med Chem. 2009 Sep 1;17(17):6360-73. doi: 10.1016/j.bmc.2009.07.025. Epub 2009 Jul 18.
Cyclitol [RCAI-37 (1), 59 (5), 92 (7), and 102 (2)] and carbasugar analogs [RCAI-56 (3), 60 (4), and 101 (6)] of KRN7000 were synthesized through coupling reactions of the corresponding cyclitol or carbasugar derivatives with a cyclic sulfamidate (9) as the key step. Bioassay showed RCAI-56 (3, carbagalactose analog of KRN7000), 59 (5, 1-deoxy-neo-inositol analog), and 92 (7, 1-O-methylated 5) to be remarkably potent stimulants of mouse lymphocytes to produce Th1-biased cytokines, such as interferon-gamma, in vivo. RCAI-60 (4, carbafucose analog) and RCAI-101 (6, 6-O-methylated 3) showed strong bioactivity, on the other hands, RCAI-37 (1, myo-inositol analog) and 102 (2, neo-inositol analog) induced little cytokine production.
通过相应的环醇或碳环糖衍生物与环氨基磺酸酯(9)的偶联反应作为关键步骤,合成了KRN7000的环醇[RCAI - 37(1)、59(5)、92(7)和102(2)]和碳环糖类似物[RCAI - 56(3)、60(4)和101(6)]。生物测定表明,RCAI - 56(3,KRN7000的碳环半乳糖类似物)、59(5,1 - 脱氧新肌醇类似物)和92(7,1 - O - 甲基化的5)在体内是小鼠淋巴细胞产生Th1偏向性细胞因子(如干扰素 - γ)的显著有效刺激物。另一方面,RCAI - 60(4,碳环岩藻糖类似物)和RCAI - 101(6,6 - O - 甲基化的3)表现出较强的生物活性,而RCAI - 37(1,肌醇类似物)和102(2,新肌醇类似物)诱导的细胞因子产生很少。